Medical Devices Analyst Jennings, along with Dr. d’Avila, Chief Cardiac Arrhythmia Service of Beth Israel Deaconess Medical Center discuss the pulsed field ablation programs for Abbott (ABT) Boston Scientific (BSX), Johnson & Johnson (JNJ) and Medtronic (MDT) on an Analyst/Industry conference call to be held on March 24 at 10:30 am. Webcast Link
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on ABT:
- DexCom pullback on Abbott news a buying opportunity, says Jefferies
- Wells downgrades Edwards Lifesciences with Medtronic gaining share
- BofA says buy DexCom on weakness after Abbott’s Libre gets pump integration
- Tandem pairing with Abbott sensors can be ‘big deal,’ says Lake Street
- Abbott: FDA clears first first commercially available TBI blood test